Morphini hydrochloridum trihydricum

Hazard statements (CLP)

H302, H317, H331, H334, H361fd, H362

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger

Hazard statements

H302 Harmful if swallowed. H331 Toxic if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child. H362 May cause harm to breast-fed children.

Precautionary statements

P201 Obtain special instructions before use. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P263 Avoid contact during pregnancy and while nursing. P280 Wear protective gloves/protective clothing/eye protection/face protection. P284 [In case of inadequate ventilation] wear respiratory protection. P304+P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P308+P313 IF expsoed or concerned: Get medicinal advice/attention. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor.

Contains

(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12- methanobenzofuro[3,2-e]isoquinoline-7,9-diol;trihydrate;hydrochloride

2.3 Other hazards

** * The Substance does not meet PBT-criteria. This substance does not meet the vPvB-criteria. This substance does not have endocrine disrupting properties with respect to humans. This substance does not have endocrine disrupting properties with respect to non-target organisms.

2.1 Classification of the substance or mixture

Classification (Regulation (EC) No. 1272/2008) Acute Tox. 4 H302 Acute Tox. 3 H331 Resp. Sens. 1 H334 Skin Sens. 1 H317 Repr. 2 H361fd Lact. H362 The product is classified and labelled in accordance with Regulation (EC) No 1272/2008 For explanation of abbreviations see section 16. 2.2. Label elements